Prakash Ramachandran retweeted
Please 🙏 can I ask everyone to share the report and event registration details widely so the measure reaches the right people 😉
Prakash Ramachandran retweeted
In MASLD, there is a close association between liver fibrosis severity and outcome.
As part of JCI’s ongoing series, Evolving Insights into MASLD and MASH Pathogenesis and Treatment with series editor Scott Friedman, Prakash Ramachandran @prakramacha & colleagues @EdinburghUni discuss the regulators of liver fibrosis and consider fibrosis mechanisms as informed by omics approaches. jci.org/articles/view/186421
Prakash Ramachandran retweeted
Review @NatRevGastroHep @ljpally19
@iit_ucl @pallett_lab @BrownRom1 @george_e_finney
Tissue-resident memory CD8+ T cells: master deciphers of the hepatic environment
nature.com/articles/s41575-0…
Prakash Ramachandran retweeted
Cynthia beautifully representing our team at #EMDS2025! Her work showing that myeloid cells are at the center of the fibrotic niche and contributes to the recruitment of bystander CD8 T cells, which are not necessary to lead to fibrosis! Proud of you! 👏👏👏
Prakash Ramachandran retweeted
Review @jclinicalinvest @prakramacha @EdinUni_IRR 🏴🇬🇧 Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics
jci.org/articles/view/186421
Check out the latest preprint from our lab. We atlas liver scRNAseq data from 77 patients and identify a new subpopulation of pro-inflammatory scar-associated macrophages which promote fibrosis. @EdinUni_IRR @EdinUni_CIR #livertwitter biorxiv.org/content/10.1101/…
The annotated data for all cell types is available to play about with on this Shiny app: shiny.igc.ed.ac.uk/Human_Liv…
Thanks to everybody who has helped with this. @TimKendall_Path @JAFallowfield @ljpally19 @elenipapachri_ @george_e_finney @CataVallejosM @hay_dave @bainlab @GastroGRJ
Prakash Ramachandran retweeted
🚨 Postdoc opportunity!
Join the prestigious EMBL-EBI–Sanger Postdoctoral (ESPOD) Programme bridging @sangerinstitute & @embl
🔬 Projects:
1️⃣ AI-driven single-cell perturbation exp design m. (with @Muzz_Haniffa @saezlab)
2️⃣ Predicting cell phenotypes of new compounds using generative modeling (with Jess Ewald)
💰 £3,383/month (after tax)
📅 36 months | Start within 12 months
⏳ Apply by 30 Sept 2025
👉 apply here; ebi.ac.uk/research/postdocs/…
#Postdoc #AI #SingleCell #Genomics #Career
Prakash Ramachandran retweeted
Replying to @biorxivpreprint
@biorxivpreprint A Human Single-cell Atlas Identifies OLR1+ Scar-associated Macrophages as a Therapeutic Target for Chronic Liver Disease
biorxiv.org/content/10.1101/…
@elenipapachri_ @prakramacha
Prakash Ramachandran retweeted
Fibrosis: cross-organ biology and pathways to development of innovative drugs | @NatRevDrugDisc @rkramann nature.com/articles/s41573-0…
Prakash Ramachandran retweeted
So pleased to be involved in this awesome new AI model for predicting microenvironment-induced cell states with @mo_lotfollahi’s lab.
Such models show huge promise for refining and prioritising laboratory research for faster clinical translation and patient benefit
(1/12) Over a year ago, we launched a new project to explore whether the tissue microenvironment could predict cellular behaviour and whether reprogramming might unlock new therapeutic avenues. 🧬 Spatial transcriptomics provides deep insights into tissue organisation.
We wanted to take this further by building a model that predicts how the tissue microenvironment rewires cells, and in silico predict how reprogramming influences the diseased microenvironment. Today, in collaboration with @Muzz_Haniffa at @sangerinstitute we’re excited to share the preprint for Mintflow, including two novel disease datasets.
Link to preprint: shorturl.at/alFUO 🧵
Prakash Ramachandran retweeted
(1/12) Over a year ago, we launched a new project to explore whether the tissue microenvironment could predict cellular behaviour and whether reprogramming might unlock new therapeutic avenues. 🧬 Spatial transcriptomics provides deep insights into tissue organisation.
We wanted to take this further by building a model that predicts how the tissue microenvironment rewires cells, and in silico predict how reprogramming influences the diseased microenvironment. Today, in collaboration with @Muzz_Haniffa at @sangerinstitute we’re excited to share the preprint for Mintflow, including two novel disease datasets.
Link to preprint: shorturl.at/alFUO 🧵
Prakash Ramachandran retweeted
We are pleased to share our review article on the role of myeloid cells in chronic liver inflammation [Cell Mol Immunol]. Congrats team [ D. Patseas, A. El-Masry, Z. Liu & P. Ramachandran @prakramacha ] and thank you to Prof. B. Gao for the invitation. rdcu.be/ex6tl
Prakash Ramachandran retweeted
Great pleasure co-authoring this review with my good friend @phil_newsome7
JCI - Therapeutic horizons in metabolic dysfunction–associated steatohepatitis jci.org/articles/view/186425…
@AASLDtweets @the_asci @EASLnews @CALonghurst @APASLnews @INASL_Liver
Prakash Ramachandran retweeted
Postdoc position in our group at @emblebi , analyzing single cell data to better understand and treat neurodegen diseases, collab with @AndrewBassett43 , @mo_lotfollahi, @bayraktar_lab M Strauss and others @OpenTargets . Deadline 20/07.
Please share🙏: embl.wd103.myworkdayjobs.com…
Prakash Ramachandran retweeted
🩸 New data add to current evidence on #PlasmaExchange in ACLF:
TPE may improve short-term survival in selected patients unresponsive
☞ More work needed to define who benefits & when #LiverTwitter #EASL #INASL #EFCLIF
jcehepatology.com/article/S0…





















